Literature DB >> 11095508

Expression of a system L neutral amino acid transporter at the blood-brain barrier.

H Matsuo1, S Tsukada, T Nakata, A Chairoungdua, D K Kim, S H Cha, J Inatomi, H Yorifuji, J Fukuda, H Endou, Y Kanai.   

Abstract

Amino acid transport system L has been proposed to be one of the major nutrient transport systems at the blood-brain barrier. Using immunohistochemical analyses, a system L transporter LAT1 was shown to be expressed in the brain capillary endothelial cells in rats. Because LAT1 was coexpressed with 4F2 heavy chain which brings LAT1 to the plasma membrane, LAT1 is proposed to be functional in the plasma membrane of brain capillary endothelial cells. Both LAT1 and 4F2hc immunoreactivities were detected in a double line appearance surrounding endothelial cell nuclei, suggesting both proteins are present in the luminal and abluminal membranes. LAT1 is, thus, a blood-brain barrier system L transporter responsible for the permeation of aromatic or branched-chain amino acids and amino acid-related drugs such as L-DOPA.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11095508     DOI: 10.1097/00001756-200011090-00021

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  47 in total

1.  Activation of system L heterodimeric amino acid exchangers by intracellular substrates.

Authors:  Christian Meier; Zorica Ristic; Stefan Klauser; François Verrey
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

2.  Effect of pluronic p85 on amino acid transport in bovine brain microvessel endothelial cells.

Authors:  Xiaobin Zhang; Daria Y Alakhova; Elena V Batrakova; Shu Li; Zhihui Yang; Yili Li; Alexander V Kabanov
Journal:  J Neuroimmune Pharmacol       Date:  2008-08-02       Impact factor: 4.147

3.  Effects of Branched-Chain Amino Acid Supplementation on Spontaneous Seizures and Neuronal Viability in a Model of Mesial Temporal Lobe Epilepsy.

Authors:  Shaun E Gruenbaum; Roni Dhaher; Amedeo Rapuano; Hitten P Zaveri; Amber Tang; Nihal de Lanerolle; Tore Eid
Journal:  J Neurosurg Anesthesiol       Date:  2019-04       Impact factor: 3.956

4.  Mechanisms and significance of the increased brain uptake of tryptophan.

Authors:  Natalie R Lenard; Adrian J Dunn
Journal:  Neurochem Res       Date:  2005-12       Impact factor: 3.996

5.  The methylmercury-L-cysteine conjugate is a substrate for the L-type large neutral amino acid transporter.

Authors:  Zhaobao Yin; Haiyan Jiang; Tore Syversen; João B T Rocha; Marcelo Farina; Michael Aschner
Journal:  J Neurochem       Date:  2008-09-13       Impact factor: 5.372

Review 6.  Strategies for delivering therapeutics across the blood-brain barrier.

Authors:  Georg C Terstappen; Axel H Meyer; Robert D Bell; Wandong Zhang
Journal:  Nat Rev Drug Discov       Date:  2021-03-01       Impact factor: 84.694

7.  LAT1 expression in normal lung and in atypical adenomatous hyperplasia and adenocarcinoma of the lung.

Authors:  Kuniaki Nakanishi; Hirotaka Matsuo; Yoshikatsu Kanai; Hitoshi Endou; Sadayuki Hiroi; Susumu Tominaga; Makio Mukai; Eiji Ikeda; Yuichi Ozeki; Shinsuke Aida; Toshiaki Kawai
Journal:  Virchows Arch       Date:  2005-09-21       Impact factor: 4.064

8.  Neutral amino acid transporter ASCT1 is preferentially expressed in L-Ser-synthetic/storing glial cells in the mouse brain with transient expression in developing capillaries.

Authors:  Kazuhisa Sakai; Hidemi Shimizu; Tatsuro Koike; Shigeki Furuya; Masahiko Watanabe
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

9.  The kynurenine pathway and inflammation in amyotrophic lateral sclerosis.

Authors:  Yiquan Chen; Roger Stankovic; Karen M Cullen; Vincent Meininger; Brett Garner; Sarah Coggan; Ross Grant; Bruce J Brew; Gilles J Guillemin
Journal:  Neurotox Res       Date:  2009-11-18       Impact factor: 3.911

10.  Correlation of L-methyl-11C-methionine (MET) uptake with L-type amino acid transporter 1 in human gliomas.

Authors:  Shuichi Okubo; Hai-Ning Zhen; Nobuyuki Kawai; Yoshihiro Nishiyama; Reiji Haba; Takashi Tamiya
Journal:  J Neurooncol       Date:  2010-01-21       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.